Year |
Citation |
Score |
2016 |
McCammon KM, Panda SP, Xia C, Kim JP, Moutinho D, Kranendonk M, Auchus RJ, Lafer EM, Ghosh D, Martasek P, Kar R, Masters BS, Roman LJ. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to its Antley-Bixler Syndrome-Like Phenotype. The Journal of Biological Chemistry. PMID 27496950 DOI: 10.1074/Jbc.M116.716019 |
0.349 |
|
2013 |
Panda SP, Li W, Venkatakrishnan P, Chen L, Astashkin AV, Masters BS, Feng C, Roman LJ. Differential calmodulin-modulatory and electron transfer properties of neuronal nitric oxide synthase mu compared to the alpha variant. Febs Letters. 587: 3973-8. PMID 24211446 DOI: 10.1016/J.Febslet.2013.10.032 |
0.376 |
|
2013 |
Panda SP, Guntur AR, Polusani SR, Fajardo RJ, Gakunga PT, Roman LJ, Masters BS. Conditional Deletion of Cytochrome P450 Reductase in Osteoprogenitor Cells Affects Long Bone and Skull Development in Mice Recapitulating Antley-Bixler Syndrome: Role of a Redox Enzyme in Development Plos One. 8. PMID 24086598 DOI: 10.1371/Journal.Pone.0075638 |
0.305 |
|
2013 |
Panda SP, Polusani SR, Kellogg DL, Venkatakrishnan P, Roman MG, Demeler B, Masters BS, Roman LJ. Intra- and inter-molecular effects of a conserved arginine residue of neuronal and inducible nitric oxide synthases on FMN and calmodulin binding. Archives of Biochemistry and Biophysics. 533: 88-94. PMID 23507581 DOI: 10.1016/J.Abb.2013.03.004 |
0.388 |
|
2012 |
Kaplánek R, Martásek P, Grüner B, Panda S, Rak J, Masters BSS, Král V, Roman LJ. Nitric oxide synthases activation and inhibition by metallacarborane- cluster-based isoform-specific affectors Journal of Medicinal Chemistry. 55: 9541-9548. PMID 23075390 DOI: 10.1021/Jm300805X |
0.315 |
|
2012 |
Moutinho D, Marohnic CC, Panda SP, Rueff J, Masters BS, Kranendonk M. Altered human CYP3A4 activity caused by antley-bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system Drug Metabolism and Disposition. 40: 754-760. PMID 22252407 DOI: 10.1124/Dmd.111.042820 |
0.376 |
|
2011 |
Xia C, Panda SP, Marohnic CC, Martaśek P, Masters BS, Kim JJP. Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency Proceedings of the National Academy of Sciences of the United States of America. 108: 13486-13491. PMID 21808038 DOI: 10.1073/Pnas.1106632108 |
0.397 |
|
2011 |
Marohnic CC, Huber Iii WJ, Patrick Connick J, Reed JR, McCammon K, Panda SP, Martásek P, Backes WL, Masters BS. Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization. Archives of Biochemistry and Biophysics. 513: 42-50. PMID 21741353 DOI: 10.1016/J.Abb.2011.06.008 |
0.408 |
|
2011 |
Polusani SR, Kar R, Riquelme MA, Masters BS, Panda SP. Regulation of gap junction function and Connexin 43 expression by cytochrome P450 oxidoreductase (CYPOR) Biochemical and Biophysical Research Communications. 411: 490-495. PMID 21726529 DOI: 10.1016/J.Bbrc.2011.06.132 |
0.331 |
|
2010 |
Marohnic CC, Panda SP, McCammon K, Rueff J, Masters BS, Kranendonk M. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 332-40. PMID 19884324 DOI: 10.1124/Dmd.109.030445 |
0.405 |
|
2009 |
Beaumont E, Lambry JC, Blanchard-Desce M, Martasek P, Panda SP, van Faassen EE, Brochon JC, Deprez E, Slama-Schwok A. NO formation by neuronal NO-synthase can be controlled by ultrafast electron injection from a nanotrigger. Chembiochem : a European Journal of Chemical Biology. 10: 690-701. PMID 19222033 DOI: 10.1002/Cbic.200800721 |
0.353 |
|
2008 |
Kranendonk M, Marohnic CC, Panda SP, Duarte MP, Oliveira JS, Masters BS, Rueff J. Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase. Archives of Biochemistry and Biophysics. 475: 93-9. PMID 18455494 DOI: 10.1016/J.Abb.2008.04.014 |
0.377 |
|
2007 |
Gao YT, Roman LJ, Martásek P, Panda SP, Ishimura Y, Masters BS. Oxygen metabolism by endothelial nitric-oxide synthase. The Journal of Biological Chemistry. 282: 28557-65. PMID 17698846 DOI: 10.1074/Jbc.M704890200 |
0.365 |
|
2007 |
Gao YT, Panda SP, Roman LJ, Martásek P, Ishimura Y, Masters BS. Oxygen metabolism by neuronal nitric-oxide synthase. The Journal of Biological Chemistry. 282: 7921-9. PMID 17229730 DOI: 10.1074/Jbc.M609814200 |
0.368 |
|
2007 |
Gao Y, Panda SP, Roman LJ, Martasek P, Ishimura Y, Masters BS. Oxygen: The Overlooked Substrate for Nitric Oxide Synthases The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A622-D |
0.343 |
|
2006 |
Marohnic CC, Panda SP, Martásek P, Masters BS. Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase Journal of Biological Chemistry. 281: 35975-35982. PMID 16998238 DOI: 10.1074/Jbc.M607095200 |
0.462 |
|
2006 |
Panda SP, Gao YT, Roman LJ, Martásek P, Salerno JC, Masters BS. The role of a conserved serine residue within hydrogen bonding distance of FAD in redox properties and the modulation of catalysis by Ca2+/calmodulin of constitutive nitric-oxide synthases. The Journal of Biological Chemistry. 281: 34246-57. PMID 16966328 DOI: 10.1074/Jbc.M601041200 |
0.411 |
|
2005 |
Jáchymová M, Martásek P, Panda S, Roman LJ, Panda M, Shea TM, Ishimura Y, Kim JJP, Masters BSS. Recruitment of governing elements for eletron transfer in the nitric oxide synthase family Proceedings of the National Academy of Sciences of the United States of America. 102: 15833-15838. PMID 16249336 DOI: 10.1073/Pnas.0506522102 |
0.361 |
|
2005 |
Ishimura Y, Gao YT, Panda SP, Roman LJ, Masters BS, Weintraub ST. Detection of nitrous oxide in the neuronal nitric oxide synthase reaction by gas chromatography-mass spectrometry. Biochemical and Biophysical Research Communications. 338: 543-9. PMID 16154533 DOI: 10.1016/J.Bbrc.2005.07.202 |
0.337 |
|
1999 |
Nishimura JS, Narayanasami R, Miller RT, Roman LJ, Panda S, Masters BSS. The stimulatory effects of Hofmeister ions on the activities of neuronal nitric-oxide synthase. Apparent substrate inhibition by L-arginine is overcome in the presence of protein-destabilizing agents Journal of Biological Chemistry. 274: 5399-5406. PMID 10026150 DOI: 10.1074/Jbc.274.9.5399 |
0.364 |
|
Show low-probability matches. |